ORAMED PHARMACEUTICALS INC. Gain (Loss) on Disposition of Assets
ORAMED PHARMACEUTICALS INC. (ORMP) reported Gain (Loss) on Disposition of Assets of $5.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-10
- ORAMED PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $0.00.
- ORAMED PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $5.82M.
- ORAMED PHARMACEUTICALS INC. gain (loss) on disposition of assets for fiscal 2022 was $13.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.82M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $5.82M 10-Q · filed 2026-05-19 | ||
| 2022-12-31 | $13.00K 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |